Skip to content
NASDAQ · SERVICES-HEALTH SERVICES · LARGE CAP

Pennant Group, Inc. PNTG

9 fiscal years on record · USD · FY2025 reported · SEC filings only
$947.7M
▲ 36.3% YoY
$29.6M
▲ 31.1% YoY
$36.3M
▲ 19.6% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

The Pennant Group, Inc. operates in multiple lines of business, including home health, hospice, and senior living services, across Alabama, Arizona, California, Colorado, Georgia, Idaho, Montana, Nevada, Oklahoma, Oregon, Tennessee, Texas, Utah, Washington, Wisconsin and Wyoming. It derives revenue from a blend of payors including Medicare and Medicaid programs, private pay patients and residents, and managed care payors. It has two reportable segments: home health and hospice services, which includes its home health, hospice, home care, and geriatric primary and palliative care businesses, and senior living services, which includes its assisted living, independent living and memory care services. As of December 31, 2025, it provided home health and hospice services through 172 agencies. Its home health services consist of a combination of clinical services, including nursing, speech, occupational and physical therapy, medical social work and home health aide services, provided within a patient's home. It generated approximately 62.5%, 64.7% and 66.9% of its home health and hospice segment revenue from Medicare during the years ended December 31, 2025, 2024, and 2023, respectively. As of December 31, 2025, it provided assisted living, independent living and memory care services in 63 communities with 4,428 total available units. The Pennant Group, Inc. was incorporated as a Delaware corporation on January 24, 2019.

Written from the business description in The Pennant Group, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 26 February 2026. Every sentence was checked against that document before publication.

Growth

USD 947.7M
Revenue, FY2025 · full 9-year series below
Revenue $M Net income $M
FY2025 · Revenue 947.7 · Net income 29.6
400M800M
2017202020232025
Compound annual growth
+26.0%
+19.4%
+64.5%
+13.4%
+56.3%
+10.1%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +19.4% a year over the five years to FY2025 — but profit grew slower: net income at +13.4%, earnings per share at +10.1%.

The share count rose from 0.03B to 0.03B over the period.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

4 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 5.5% · Net 3.6%
2%4%6%
201720212025
ROE
FY2025 · ROE 8.6%
10%20%
201720212025
Three returns, three denominators.

Each USD of equity produced 9 cents of profit this year.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 36.3
20M40M-10M-20M
201720212025
Net buybacks $M Dividends $M
FY2022 · Dividends · · Net buybacks -1.1
5M10M
201720182019202020212022

Total assetsUSD 968.2M
CashUSD 17.0M
Gross debtUSD 173.8M
Net debtUSD 156.8M
Current ratio1.14×

Net debt stands at 42% of equity.

The 9-year record

9 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative—not applicable◌not available in our data
PNTG, 9-year financial record
Metric 202520242023202220212020201920182017
Revenue $B0.90.70.50.50.40.40.30.30.3
Operating income $B0.10.00.00.00.00.00.00.00.0
EBITDA $B0.10.00.00.00.00.00.00.00.0
Income tax $B0.00.00.00.00.00.00.00.00.0
Net income $B0.00.00.00.00.00.00.00.00.0
Free cash flow $B0.00.00.0−0.0−0.00.00.00.00.0
EPS, diluted $0.840.700.440.220.090.520.110.580.36
Dividend / sh $◌◌◌◌◌◌◌◌◌
Payout %————0045600
ROE %8.69.99.95.52.518.33.725.116.5
Shares out B0.030.030.030.030.030.030.03◌◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 34 reconciliationsAUDITED

Reconciled in 9 of the 9 fiscal years we could check. 22 checks were skipped: the balance sheet is not tagged before 2018. 10 checks were skipped: EPS is not tagged before 2017. 10 checks were skipped: revenue is not tagged before 2017.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityServices-Health Services
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2017

Share this section

Download image